Terminated NA INTERVENTIONAL 1-arm NCT02587377

New Biomarkers for Invasive Fungal Infections in Paediatric Haemato-oncology

New Biomarkers for Invasive Fungal Infections in Paediatric Haemato-oncology. A National Belgian Study

Sponsor: Merck Sharp & Dohme LLC

Conditions Haemato-oncological Paediatric Patients Under Intensive Chemotherapy

Interventions Non Standard of Care blood samples collection

Updated 6 times since 2017 Last updated: Oct 26, 2015 Started: Jun 30, 2013 Primary completion: Apr 30, 2014 Completion: Apr 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

The current rate of recruitment is insufficient.

Other terminated trials from Merck Sharp & Dohme LLC

More terminations from Merck Sharp & Dohme LLC

This NA trial investigates Haemato-oncological Paediatric Patients Under Intensive Chemotherapy and is currently terminated or withdrawn. Merck Sharp & Dohme LLC leads this study, which shows 6 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jun 2022 — Jul 2024 [monthly]

Terminated NA
Jan 2021 — Jun 2022 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Terminated NA

First recorded

Jun 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Merck Sharp & Dohme LLC
Queen Fabiola Children's University Hospital

Data source: Queen Fabiola Children's University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.